FDA backs development of radiation-sickness countermeasures

08/13/2013 | GenomeWeb Daily News (free registration)

The Wyss Institute at Harvard University will use its organs-on-chips technology to evaluate medical countermeasures against acute radiation syndrome, or ARS, under a $5.6 million grant from the FDA. As part of the contract, scientists at Wyss will test possible countermeasures for ARS on models of radiation damage in bone marrow, gut and lung organs-on-chips.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations